Alan Fuhrman - Net Worth and Insider Trading

Alan Fuhrman Net Worth

The estimated net worth of Alan Fuhrman is at least $211,495 dollars as of 2024-11-05. Alan Fuhrman is the CFO of Tyra Biosciences Inc and owns about 12,849 shares of Tyra Biosciences Inc (TYRA) stock worth over $211,495. Alan Fuhrman is also the Director of Loxo Oncology Inc and owns about 0 shares of Loxo Oncology Inc (LOXO) stock worth over $0. Details can be seen in Alan Fuhrman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan Fuhrman has not made any transactions after 2024-10-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Alan Fuhrman

To

Alan Fuhrman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alan Fuhrman owns 7 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , Esperion Therapeutics Inc (ESPR) , and SpringWorks Therapeutics Inc (SWTX) among others .

Click here to see the complete history of Alan Fuhrman’s form 4 insider trades.

Insider Ownership Summary of Alan Fuhrman

Ticker Comapny Transaction Date Type of Owner
CMPI Checkmate Pharmaceuticals Inc 2020-08-06 director
ESPR Esperion Therapeutics Inc 2020-03-16 director
SWTX SpringWorks Therapeutics Inc 2020-05-20 director
LIMIT LIMIT 2019-02-15 director
LIMIT LIMIT 2015-09-30 Chief Financial Officer
LIMIT LIMIT 2004-09-15 Senior Vice President & CFO
LIMIT LIMIT 2023-01-01 Chief Financial Officer

Alan Fuhrman Latest Holdings Summary

Alan Fuhrman currently owns a total of 2 stocks. Among these stocks, Alan Fuhrman owns 12,849 shares of Tyra Biosciences Inc (TYRA) as of October 30, 2024, with a value of $211,495 and a weighting of 100%. Alan Fuhrman also owns 0 shares of Loxo Oncology Inc (LOXO) as of June 8, 2018, with a value of $0 and a weighting of 0%.

Latest Holdings of Alan Fuhrman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TYRA Tyra Biosciences Inc 2024-10-30 12,849 16.46 211,495
LOXO Loxo Oncology Inc 2018-06-08 0 234.66 0

Holding Weightings of Alan Fuhrman


Alan Fuhrman Form 4 Trading Tracker

According to the SEC Form 4 filings, Alan Fuhrman has made a total of 1 transactions in Tyra Biosciences Inc (TYRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tyra Biosciences Inc is the acquisition of 9,500 shares on October 30, 2024, which cost Alan Fuhrman around $152,000.

According to the SEC Form 4 filings, Alan Fuhrman has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 2,625 shares on June 8, 2018, which brought Alan Fuhrman around $467,434.

Insider Trading History of Alan Fuhrman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alan Fuhrman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alan Fuhrman Ownership Network

Ownership Network List of Alan Fuhrman

No Data

Ownership Network Relation of Alan Fuhrman

Insider Network Chart

Alan Fuhrman Owned Company Details

What does Checkmate Pharmaceuticals Inc do?

Who are the key executives at Checkmate Pharmaceuticals Inc?

Alan Fuhrman is the director of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .

Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Checkmate Pharmaceuticals Inc Insider Transactions

No Available Data

Alan Fuhrman Mailing Address

Above is the net worth, insider trading, and ownership report for Alan Fuhrman. You might contact Alan Fuhrman via mailing address: C/o Ambit Biosciences Corporation, 11080 Roselle Street, San Diego Ca 92121.